
Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Tzrifin base exhibition reveals Hamas and Hezbollah arms, showing structure behind attacks - 2
Figure out How to Plan for Your Web-based Degree monetarily - 3
Find the Keys to Fruitful Venture The board: Conveying Results on Time - 4
Manual for Tracking down Spending plan Agreeable Travel Objections - 5
South Carolina measles outbreak grows by nearly 100, spreads to North Carolina and Ohio
Watch Chinese astronauts enjoy '1st ever space BBQ' from Tiangong's brand-new oven (video)
Trouvez La Carte De Cr\u00e9dit Id\u00e9ale Pour Vos Besoins En Belgique
How Mars' ancient lakes grew shields of ice to stay warm as the Red Planet froze
I work with companies to confront addiction in the workplace. The hidden crisis is costing corporate America millions.
'Malcolm in the Middle' reboot releases 1st trailer, reuniting Frankie Muniz and Bryan Cranston: Watch here
Dave Coulier shares new cancer diagnosis 1 year after revealing previous diagnosis
Which sandwich do you find totally delectable? !
Putin critic gets six years in penal colony, vows hunger strike
Poll: Most are satisfied with their health insurance, but a quarter report denials or delays













